Valuation for ANEB - findataslice

	Anebulo Pharmaceuticals, Inc.
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date			2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31	2023-Sep-30	2023-Jun-30	2023-Mar-31	2022-Dec-31	2022-Sep-30	2022-Jun-30	2022-Mar-31	2021-Dec-31	2021-Sep-30		2021-Mar-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023	Q3-FY2023	Q2-FY2023	Q1-FY2023	Q4-FY2022	Q3-FY2022	Q2-FY2022	Q1-FY2021		Q3-FY2020
Close Price of Common Stock	2.29$	2.37$	1.48$	1.35$	1.72$	1.92$	2.68$	2.91$	2.54$	3.19$	2.48$	2.88$	2.43$	3.11$	4.72$	6.01$	6.31$	7.01$
Market Cap of Common Stock	94,084,034$	97,370,812$	60,805,402$	55,464,387$	44,605,133$	49,791,777$	69,501,022$	75,465,661$	65,108,371$	81,769,962$	63,570,378$	73,823,665$	62,288,717$	72,676,243$	110,186,356$	140,300,848$	147,304,218$	163,645,415$
Market Cap of Common Stock QoQ%	(3.38%)	60.14%	9.63%	24.35%	(10.42%)	(28.36%)	(7.90%)	15.91%	(20.38%)	28.63%	(13.89%)	18.52%	(14.29%)	(34.04%)	(21.46%)	(4.75%)
Market Cap of Common Stock YoY%	110.93%	95.56%	(12.51%)	(26.50%)	(31.49%)	(39.11%)	9.33%	2.22%	4.53%	12.51%	(42.31%)	(47.38%)	(57.71%)
Common Shares Outstanding		41,084,731	41,084,731	41,084,731	41,084,731	25,933,217	25,933,217	25,933,217	25,933,217	25,633,217	25,633,217	25,633,217	25,633,217	25,633,217	23,344,567	23,344,567	23,344,567	23,344,567		12,982,500	12,982,500	12,982,500	12,000,000
Common Shares Outstanding QoQ%		.00%	.00%	.00%	58.43%	.00%	.00%	.00%	1.17%	.00%	.00%	.00%	.00%	9.80%	.00%	.00%				.00%	.00%	8.19%
Common Shares Outstanding YoY%		58.43%	58.43%	58.43%	58.43%	1.17%	1.17%	1.17%	1.17%	.00%	9.80%	9.80%	9.80%					79.82%
Total Revenue TTM
Total Revenue
Total Revenue QoQ%
Total Revenue YoY%
Gross Margin
Earnings to Common Shareholders TTM			(8,484,763$)	(7,689,904$)	(7,667,277$)	(7,921,616$)	(8,201,703$)	(9,347,314$)	(10,491,743$)	(11,601,326$)	(11,732,338$)	(11,559,500$)	(10,638,020$)	(7,884,059$)						(9,523,845$)
Earnings to Common Shareholders			(2,144,828$)	(1,676,169$)	(2,463,030$)	(2,200,736$)	(1,349,969$)	(1,653,542$)	(2,717,369$)	(2,480,823$)	(2,495,580$)	(2,797,971$)	(3,826,952$)	(2,611,835$)	(2,322,742$)	(1,876,491$)	(1,072,991$)	(1,553,395$)		(8,764,225$)	(328,604$)	(256,379$)	(174,637$)
Earnings to Common Shareholders QoQ%			(27.96%)	31.95%	(11.92%)	(63.02%)	18.36%	39.15%	(9.54%)	.59%	10.81%	26.89%	(46.52%)	(12.45%)	(23.78%)	(74.88%)				(2,567.11%)	(28.17%)	(46.81%)
Earnings to Common Shareholders YoY%			(58.88%)	(1.37%)	9.36%	11.29%	45.91%	40.90%	28.99%	5.02%	(7.44%)	(49.11%)	(256.66%)					(505.90%)
Profit Margin
Equity to Common Shareholders			11,657,928$	13,462,452$	14,962,421$	1,898,715$	3,812,531$	4,985,314$	6,487,217$	8,331,324$	10,601,350$	12,941,521$	15,515,855$	19,117,186$	15,066,900$	17,162,690$	18,913,927$	19,892,636$		(9,435,836$)	(719,018$)	(411,108$)	(171,137$)
Equity to Common Shareholders QoQ			(1,804,524$)	(1,499,969$)	13,063,706$	(1,913,816$)	(1,172,783$)	(1,501,903$)	(1,844,107$)	(2,270,026$)	(2,340,171$)	(2,574,334$)	(3,601,331$)	4,050,286$	(2,095,790$)	(1,751,237$)				(8,716,818$)	(307,910$)	(239,971$)
Equity to Common Shareholders QoQ%			(13.40%)	(10.03%)	688.03%	(50.20%)	(23.53%)	(23.15%)	(22.14%)	(21.41%)	(18.08%)	(16.59%)	(18.84%)	26.88%	(12.21%)	(9.26%)				(1,212.32%)	(74.90%)	(140.22%)
Equity to Common Shareholders YoY			7,845,397$	8,477,138$	8,475,204$	(6,432,609$)	(6,788,819$)	(7,956,207$)	(9,028,638$)	(10,785,862$)	(4,465,550$)	(4,221,169$)	(3,398,072$)					20,303,744$
Equity to Common Shareholders YoY%			205.78%	170.04%	130.65%	(77.21%)	(64.04%)	(61.48%)	(58.19%)	(56.42%)	(29.64%)	(24.60%)	(17.97%)					4,938.79%
Dividends Paid
Additional Paid-In Capital QoQ			340,304$	176,200$	15,511,584$	286,920$	177,186$	151,639$	872,962$	210,797$	155,409$	223,637$	225,621$	6,659,832$	226,952$	125,254$
Treasury Stock
Treasury Stock QoQ
Price to Sales
Price to Earnings	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price to Book	8.07x	8.35x	5.22x	4.12x	2.98x	26.22x	18.23x	15.14x	10.04x	9.81x	6.00x	5.70x	4.01x	3.80x	7.31x	8.17x	7.79x	8.23x
Goodwill
Goodwill QoQ%
Goodwill YoY%
Other Intangible Assets
Other Intangible Assets QoQ
Amortization of Intangible Assets
Forward Price to Sales MRQ
Forward Price to Earnings MRQ	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets			12,145,616$	14,008,484$	15,841,220$	2,467,940$	4,073,114$	5,995,635$	7,500,773$	9,047,884$	11,670,151$	14,432,606$	16,888,256$	19,815,365$	15,579,431$	17,248,467$	18,963,871$	20,500,342$		4,291,475$			3,028,480$
Total Assets QoQ			(1,862,868$)	(1,832,736$)	13,373,280$	(1,605,174$)	(1,922,521$)	(1,505,138$)	(1,547,111$)	(2,622,267$)	(2,762,455$)	(2,455,650$)	(2,927,109$)	4,235,934$	(1,669,036$)	(1,715,404$)
Total Assets YoY			8,072,502$	8,012,849$	8,340,447$	(6,579,944$)	(7,597,037$)	(8,436,971$)	(9,387,483$)	(10,767,481$)	(3,909,280$)	(2,815,861$)	(2,075,615$)
Total Liabilities			487,688$	546,032$	878,799$	569,225$	260,583$	1,010,321$	1,013,556$	716,560$	1,068,801$	1,491,085$	1,372,401$	698,179$	512,531$	85,777$	49,944$	607,706$		10,751,559$			223,865$
Total Liabilities QoQ			(58,344$)	(332,767$)	309,574$	308,642$	(749,738$)	(3,235$)	296,996$	(352,241$)	(422,284$)	118,684$	674,222$	185,648$	426,754$	35,833$
Total Liabilities YoY			227,105$	(464,289$)	(134,757$)	(147,335$)	(808,218$)	(480,764$)	(358,845$)	18,381$	556,270$	1,405,308$	1,322,457$
Current Ratio																				13.30x			13.53x
Total Current Assets			11,962,506$	13,807,935$	15,395,489$	1,962,513$	3,507,990$	5,370,815$	6,816,257$		11,670,151$									3,898,745$			3,028,480$
Total Current Assets QoQ			(1,845,429$)	(1,587,554$)	13,432,976$	(1,545,477$)	(1,862,825$)	(1,445,442$)
Total Current Liabilities																				293,166$			223,865$
Total Current Liabilities QoQ
Debt to Asset Ratio			.04x	.04x	.06x	.23x	.06x	.17x	.14x	.08x	.09x	.10x	.08x	.04x	.03x	-	-	.03x		2.51x			.07x
Long Term Debt
Long Term Debt QoQ
Long Term Debt YoY
Capital Lease Obligations
Interest Expenses			300,000$	100,000$			108,466$	59,696$	31,838$											3,701$			1,286$
Cash and Cash Equivalents			11,627,849$	13,279,901$	14,998,467$	1,404,211$	3,094,200$	5,147,139$	6,644,517$	8,520,578$	11,247,403$									3,307,083$			3,024,980$
Cash and Cash Equivalents QoQ			(1,652,052$)	(1,718,566$)	13,594,256$	(1,689,989$)	(2,052,939$)	(1,497,378$)	(1,876,061$)	(2,726,825$)
Cash and Cash Equivalents YoY			8,533,649$	8,132,762$	8,353,950$	(7,116,367$)	(8,153,203$)
Interest Income